FOXO3 and prostate carcinoma: miR-592 is a cell cycle inhibitor, as mentioned in a previous study (64), and cyclin D1 is a cell cycle activator, confirming the influence of miR-592 on the regulatory effect of FOXO3a on the prostate cancer cell cycle (65).